High-throughput analyses of RNA and protein expression are increasingly used for better understanding of vaccine-induced immunity and protection against infectious disease. With an increasing number of vaccine candidates in clinical development, it is timely to consider standardisation and harmonisation of sample collection, storage and analysis to ensure results of highest quality from these precious samples. These challenges were discussed by a group of international experts during a workshop organised by TRANSVAC, a European Commission-funded Research Infrastructure project. The main conclusions were: Platforms are rarely standardised for use in preclinical and clinical studies. Coordinated efforts should continue to harmonise the experimental set up of these studies, as well as the establishment of internal standards and controls. This will ensure comparability, efficiency and feasibility of the global analyses performed on preclinical and clinical data sets. © 2014 The Authors.
Dutruel, C., Thole, J., Geels, M., Mollenkopf, H. J., Ottenhoff, T., Guzman, C. A., … Kaufmann, S. H. E. (2014). TRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: “How can big data help?” Vaccine, 32(35), 4365–4368. https://doi.org/10.1016/j.vaccine.2014.06.014